Suppr超能文献

[乙型肝炎所致肝硬化患者的小肝细胞癌:MRI与MDCT的比较]

[Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].

作者信息

Jiang Yuan-yuan, Wang Xiao-ying, Guo Xue-mei, Jiang Xue-xiang

机构信息

Department of Medical Imaging, Peking University First Hospital, Beijing 100034, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Dec 18;42(6):767-72.

Abstract

OBJECTIVE

To compare efficacy of plain and contrast enhancement MRI (1.5T or 3T) and dynamic contrast enhanced multidetector CT (MDCT, 16- or 64 -slice) for the detection of small hepatocellular carcinoma (HCC) in patients with hepatitis B-induced cirrhosis.

METHODS

A total of 21 patients (18 men, 3 women; age range, 44-74 years) with 22 small HCC and liver cirrhosis were enrolled, all having undergone MDCT and MRI within one month. The diagnosis of small HCC was established at surgical resection (n=4), percutaneous biopsy (n=1), with positive tumor staining at intervention or from combined clinical data, typical imaging features and follow-up for a period of at least one year. Triple-phase or dual-phase dynamic contrast enhancement was performed on a 16- or 64-slice MDCT. MRI sequences included transverse T1-weighed images acquired as fast spoiled gradient (FSPGR) in-phase and out-of-phase dual-echo, transverse T2-weighed images with respiratory triggering acquired as fat-suppressed fast spin echo (FSE) or fast recovery fast spin echo (FRFSE), and breath-hold coronal T2-weighed images acquired as single shot fast spin echo (SSFSE) or fast imaging employing steady-state acquisition (FIESTA). CT and MRI observers independently analyzed each image in random order and marked each lesion detected with a score, ranking from 1 to 5 (1 definitely benign, 2 possibly benign, 3 undetermined, 4 possible HCC, and 5 definite HCC), then receiver operating characteristic (ROC) curve and Chi-square analysis were adopted to compare the efficacy for MDCT and MRI imaging.

RESULTS

Although no significant difference was demonstrated at the comparison of sensitivity and specificity (sensitivity and specificity of MDCT: 70%, 50%; sensitivity and specificity of MRI 86.36%, 100%; sensitivity χ2=0.835, P=0.360; specificity χ2=1.379, P=0.240), the Az (area under the ROC curve) for MRI imaging (mean, 0.974) was much higher than that for MDCT (mean, 0.795) with significant difference (P<0.05).

CONCLUSION

MRI imaging shows better diagnostic accuracy for the detection of small HCC in patients with hepatitis B-induced cirrhosis and is recommended to improve the detection and diagnosis.

摘要

目的

比较普通及增强MRI(1.5T或3T)与动态增强多排CT(MDCT,16层或64层)对乙型肝炎肝硬化患者小肝细胞癌(HCC)的检测效能。

方法

纳入21例(18例男性,3例女性;年龄范围44 - 74岁)患有22个小HCC及肝硬化的患者,均在1个月内接受了MDCT和MRI检查。小HCC的诊断通过手术切除(n = 4)、经皮活检(n = 1)确定,或依据介入时肿瘤染色阳性、综合临床资料、典型影像特征及至少1年的随访确定。16层或64层MDCT行三期或双期动态增强扫描。MRI序列包括采用快速扰相梯度回波(FSPGR)同相位和反相位双回波采集的横轴位T1加权像、采用脂肪抑制快速自旋回波(FSE)或快速恢复快速自旋回波(FRFSE)并触发呼吸采集的横轴位T2加权像,以及采用单次激发快速自旋回波(SSFSE)或稳态进动快速成像(FIESTA)屏气采集的冠状位T2加权像。CT和MRI观察者独立随机顺序分析每张图像,并用1至5分对检测到的每个病变进行评分(1分肯定为良性,2分可能为良性,3分不确定,4分可能为HCC,5分肯定为HCC),然后采用受试者操作特征(ROC)曲线和卡方分析比较MDCT和MRI成像的效能。

结果

虽然在敏感性和特异性比较上未显示出显著差异(MDCT的敏感性和特异性:70%,50%;MRI的敏感性和特异性:86.36%,100%;敏感性χ2 = 0.835,P = 0.360;特异性χ2 = 1.379,P = 0.240),但MRI成像的Az(ROC曲线下面积)(均值,0.974)远高于MDCT(均值,0.795),差异有统计学意义(P < 0.05)。

结论

MRI成像对乙型肝炎肝硬化患者小HCC的检测具有更好的诊断准确性,推荐用于提高检测和诊断水平。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验